BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 19084153)

  • 1. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors.
    Menyhay SZ; Maki DG
    Am J Infect Control; 2008 Dec; 36(10):S174.e1-5. PubMed ID: 19084153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap.
    Menyhay SZ; Maki DG
    Infect Control Hosp Epidemiol; 2006 Jan; 27(1):23-7. PubMed ID: 16418982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
    Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
    J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of universal disinfectant cap implementation on central line-associated bloodstream infections.
    Merrill KC; Sumner S; Linford L; Taylor C; Macintosh C
    Am J Infect Control; 2014 Dec; 42(12):1274-7. PubMed ID: 25465256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
    León C; Alvarez-Lerma F; Ruiz-Santana S; González V; de la Torre MV; Sierra R; León M; Rodrigo JJ
    Crit Care Med; 2003 May; 31(5):1318-24. PubMed ID: 12771597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of disinfectable needle-free connectors.
    Yébenes JC; Serra-Prat M
    Am J Infect Control; 2008 Dec; 36(10):S175.e1-4. PubMed ID: 19084154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective clinical trial to evaluate the microbial barrier of a needleless connector.
    Casey AL; Burnell S; Whinn H; Worthington T; Faroqui MH; Elliott TS
    J Hosp Infect; 2007 Mar; 65(3):212-8. PubMed ID: 17241691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of needleless connectors on catheter-related bloodstream infections.
    Btaiche IF; Kovacevich DS; Khalidi N; Papke LF
    Am J Infect Control; 2011 May; 39(4):277-83. PubMed ID: 21256629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The coated antiseptic tip (CAT) syringe.
    Mariyaselvam M; Hodges E; Richardson J; Steel A; Moondi P; Young P
    J Med Eng Technol; 2015; 39(5):259-63. PubMed ID: 25970696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity.
    Hong H; Morrow DF; Sandora TJ; Priebe GP
    Am J Infect Control; 2013 Aug; 41(8):e77-9. PubMed ID: 23394859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro evaluation of disinfection protocols used for needleless connectors of central venous catheters.
    Mazher MA; Kallen A; Edwards JR; Donlan RM
    Lett Appl Microbiol; 2013 Oct; 57(4):282-7. PubMed ID: 23710651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequate disinfection of a split-septum needleless intravascular connector with a 5-second alcohol scrub.
    Rupp ME; Yu S; Huerta T; Cavalieri RJ; Alter R; Fey PD; Van Schooneveld T; Anderson JR
    Infect Control Hosp Epidemiol; 2012 Jul; 33(7):661-5. PubMed ID: 22669226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of three different valve systems of needle-free closed connectors in avoiding access of microorganisms to endovascular catheters after incorrect handling.
    Yébenes JC; Delgado M; Sauca G; Serra-Prat M; Solsona M; Almirall J; Capdevila JA; Balanzó X
    Crit Care Med; 2008 Sep; 36(9):2558-61. PubMed ID: 18679126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro comparison of standard cleaning to a continuous passive disinfection cap for the decontamination of needle-free connectors.
    Casey AL; Karpanen TJ; Nightingale P; Elliott TSJ
    Antimicrob Resist Infect Control; 2018; 7():50. PubMed ID: 29632665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream infection related to catheter connections: a prospective trial of two connection systems.
    Esteve F; Pujol M; Limón E; Saballs M; Argerich MJ; Verdaguer R; Mañez R; Ariza X; Gudiol F
    J Hosp Infect; 2007 Sep; 67(1):30-4. PubMed ID: 17719682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal intravenous access cleaning device fails to sterilize stopcocks.
    Holroyd JL; Paulus DA; Rand KH; Enneking FK; Morey TE; Rice MJ
    Anesth Analg; 2014 Feb; 118(2):333-343. PubMed ID: 24445634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of microbial contamination on the outer surface of needleless connectors before and after disinfection.
    Akbıyık A; Kaya S; Aksun M
    Intensive Crit Care Nurs; 2023 Aug; 77():103414. PubMed ID: 36801154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding innovative practices and technology to central line bundle reduces bloodstream infection rate in challenging pediatric population.
    Pavia M; Mazza M
    Am J Infect Control; 2016 Jan; 44(1):112-4. PubMed ID: 26769282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: Catheter-related bloodstream infection rates in relation to clinical practice and needleless device type.
    Blake M
    Can J Infect Control; 2008; 23(3):156-60, 162. PubMed ID: 19024809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.